Apigenin and cancer chemoprevention

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 663-689

  Shukla, Sanjeev ^a   Gupta, Sanjay ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apigenin; Apoptosis; Cell cycle; Chemoprevention; Flavonoids

Indexed keywords

EID: 84876131454     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374628-3.00041-4     Document Type: Chapter

References (158)

1. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutrition and Cancer 1994, 22:175-184.
2. Knekt P., Järvinen R., Seppänen R., Hellövaara M., Teppo L., Pukkala E., Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology 1997, 146:223-230.
3. Gates M.A., Tworoger S.S., Hecht J.L., De Vivo I., Rosner B., Hankinson S.E. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. International Journal of Cancer 2007, 121:2225-2232.
4. Rossi M., Negri E., Lagiou P., Talamini R., Dal Maso L., Montella M., Franceschi S., La Vecchia C. Flavonoids and ovarian cancer risk: A case-control study in Italy. International Journal of Cancer 2008, 123:895-898.
5. Hoensch H., Groh B., Edler L., Kirch W. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World Journal of Gastroenterology 2008, 14:2187-2193.
6. Chemical Sources International (2000). All chemical suppliers for apigenin. Chem. Sources Chemical Search. http://www.kw1.innova.net.
7. McKay D.L., Blumberg J.B. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutitaL.). Phytotherapy Research 2006, 20:519-530.
8. Bevilacqua L., Buiarelli F., Coccioli F., Jasionowska R. Identification of compounds in wine by HPLC-tandem mass spectrometry. Annali di Chimica 2004, 94:679-689.
9. Gerhauser C. Beer constituents as potential cancer chemopreventive agents. European Journal of Cancer 2005, 41:1941-1954.
10. Svehlikova V., Bennett R.N., Mellon F.A., Needs P.W., Piacente S., Kroon P.A., Bao Y. Isolation, identification and stability of acylated derivatives of apigenin 7-O-glucoside from chamomile (Chamomilla recutita [L.] Rauschert). Phytochemistry 2004, 65:2323-2332.
11. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 1995, 155:381-386.
12. de Vries J.H., Janssen P.L., Hollman P.C., van Staveren W.A., Katan M.B. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Letters 1997, 114:141-144.
13. Johannot L., Somerset S.M. Age-related variations in flavonoid intake and sources in the Australian population. Public Health Nutrition 2006, 8:1045-1054.
14. Wen X., Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metabolism and Disposition 2006, 34:1786-1792.
15. Wen X., Walle T. Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 2006, 36:387-397.
16. Walle T., Ta N., Kawamori T., Wen X., Tsuji P.A., Walle U.K. Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones. Biochemical Pharmacology 2007, 73:1288-1296.
17. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annual Review of Nutrition 2002, 22:19-34.
18. Hollman P.C., van Trijp J.M., Buysman M.N., van der Gaag M.S., Mengelers M.J., de Vries J.H., Katan M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Letters 1997, 418:152-156.
19. Aziz A.A., Edwards C.A., Lean M.E., Crozier A. Absorption and excretion of conjugated flavonols, including quercetin-4?-O-beta-glucoside and isorhamnetin-4?-O-beta-glucoside by human volunteers after the consumption of onions. Free Radical Research 1998, 29:257-269.
20. Chen J., Lin H., Hu M. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition. Journal of Pharmacology and Experimental Therapeutics 2003, 304:1228-1235.
21. Chen J., Wang S., Jia X., Bajimaya S., Lin H., Tam V.H., Hu M. Disposition of flavonoids via recycling: Comparison of intestinal versus hepatic disposition. Drug Metabolism and Disposition 2005, 33:1777-1784.
22. Walle U.K., Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids - structural requirements. Drug Metabolism and Disposition 2002, 30:564-569.
23. Meyer H., Bolarinwa A., Wolfram G., Linseisen J. Bioavailability of apigenin from apiin-rich parsley in humans. Annals of Nutrition and Metabolism 2006, 50:167-172.
24. Gradolatto A., Basly J.P., Berges R., Teyssier C., Chagnon M.C., Siess M.H., Canivenc-Lavier M.C. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metabolism and Disposition 2005, 33:49-54.
25. Chen T., Li L.P., Lu X.Y., Jiang H.D., Zeng S. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. Journal of Agricultural and Food Chemistry 2007, 55:273-277.
26. Gupta S., Afaq F., Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochemical and Biophysical Research Communications 2001, 287:914-920.
27. Birt D.F., Walker B., Tibbel M.G., Bresnick E. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 1986, 7:959-963.
28. Kuo M.L., Lee K.C., Lin J.K. Genotoxicities of nitropyrenes and their modulation by apigenin, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systems. Mutation Research 1992, 270:87-95.
29. Middleton E.J.R., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000, 52:673-751.
30. Birt D.F., Mitchell D., Gold B., Pour P., Pinch H.C. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Research 1997, 17:85-91.
31. Van Dross R., Xue Y., Knudson A., Pelling J.C. The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. Journal of Nutrition 2003, 133:3800S-3804S.
32. Wei H., Tye L., Bresnick E., Birt D.F. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Research 1990, 50:499-502.
33. Myhrstad M.C., Carlsen H., Nordstrom O., BlomhoffR., Moskaug J.O. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radical Biology and Medicine 2002, 32:386-393.
34. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20:1945-1952.
35. Kawai M., Hirano T., Higa S., Arimitsu J., Maruta M., Kuwahara Y., Ohkawara T., Hagihara K., Yamadori T., Shima Y., Ogata A., Kawase I., Tanaka T. Flavonoids and related compounds as anti-allergic substances. Allergology International 2007, 56:113-123.
36. Yano S., Umeda D., Yamashita T., Ninomiya Y., Sumida M., Fujimura Y., Yamada K., Tachibana H. Dietary flavones suppresses IgE and Th2 cytokines in OVA-immunized BALB/c mice. European Journal of Nutrition 2007, 46:257-263.
37. Choi J.S., Choi Y.J., Park S.H., Kang J.S., Kang Y.H. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: Role of nuclear factor-kappa B. Journal of Nutrition 2004, 4:1013-1019.
38. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radical Biology and Medicine 2004, 36:838-849.
39. Lee S.F., Lin J.K. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutrition and Cancer 1997, 28:177-183.
40. Lin J.K., Chen Y.C., Huang Y.T., Lin-Shiau S.Y. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. Journal of Cellular Biochemistry Supplement 1997, 28-29:39-48.
41. Mounho B.J., Thrall B.D. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicology and Applied Pharmacology 1999, 159:125-133.
42. Shukla S., Gupta S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 2007, 6:1102-1114.
43. Carrillo C., Cafferatam E.G., Genovese J., O'Reilly M., Roberts A.B., Santa-Coloma T.A. TGF-beta1 up-regulates the mRNA for the Na+/Ca2+ exchanger in neonatal rat cardiac myocytes. Cellular and Molecular Biology 1998, 44:543-551.
44. Yin F., Giuliano A.E., Van Herle A.J. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Research 1999, 19:4297-4303.
45. Hessenauer A., Montenarh M., Gotz C. Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells. International Journal of Oncology 2003, 22:1263-1270.
46. Landesman-Bollag E., Song D.H., Romieu-Mourez R., Sussman D.J., CardiffR.D., Sonenshein G.E., Seldin D.C. Protein kinase CK2: Signaling and tumorigenesis in the mammary gland. Molecular and Cellular Biochemistry 2001, 227:153-165.
47. Plaumann B., Fritsche M., Rimpler H., Brandner G., Hess R.D. Flavonoids activate wild-type p53. Oncogene 1996, 13:1605-1614.
48. Lepley D.M., Pelling J.C. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Molecular Carcinogenesis 1997, 19:74-82.
49. Gupta S., Afaq F., Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 2002, 21:3727-3738.
50. Shukla S., Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Molecular Carcinogenesis 2004, 39:114-126.
51. Wang I.K., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. European Journal of Cancer 1999, 35:1517-1525.
52. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Bioscience Biotechnology and Biochemistry 2000, 64:1813-1820.
53. Hirano T., Oka K., Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Research Communications in Chemical Pathology and Pharmacology 1989, 64:69-78.
54. Lindenmeyer F., Li H., Menashi S., Soria C., Lu H. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutrition and Cancer 2001, 39:139-147.
55. Panes J., Gerritsen M.E., Anderson D.C., Miyasaka M., Granger D.N. Apigenin inhibits tumor necrosis factor-induced intercellular adhesion molecule-1 upregulation in vivo. Microcirculation 1996, 3:279-286.
56. Piantelli M., Rossi C., Iezzi M., La Sorda R., Iacobelli S., Alberti S., Natali P.G. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. Journal of Cellular Physiology 2006, 207:23-29.
57. Osada M., Imaoka S., Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Letters 2004, 575:59-63.
58. Fang J., Xia C., Cao Z., Zheng J.Z., Reed E., Jiang B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB Journal 2005, 19:342-353.
59. Le Bail J.C., Laroche T., Marre-Fournier F., Habrioux G. Aromatase and 17 beta-hydroxysteroid dehydrogenase inhibition by flavonoids. Cancer Letters 1998, 133:101-106.
60. Hiremath S.P., Badami S., Hunasagatta S.K., Patil S.B. Antifertility and hormonal properties of flavones of Striga orobanchioides. European Journal of Pharmacology 2000, 391:193-197.
61. Mak P., Leung Y.K., Tang W.Y., Harwood C., Ho S.M. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia 2006, 8:896-904.
62. Shukla S., Mishra A., Fu P., MacLennan G.T., Resnick M.I., Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB Journal 2005, 19:2042-2044.
63. Shukla S., MacLennan G.T., Flask C.A., Fu P., Mishra A., Resnick M.I., Gupta S. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Research 2007, 67:6925-6935.
64. Menichincheri M., Ballinari D., Bargiotti A., Bonomini L., Ceccarelli W., D'Alessio R., Fretta A., Moll J., Polucci P., Soncini C., Tibolla M., Trosset J.Y., Vanotti E. Catecholic flavonoids acting as telomerase inhibitors. Journal of Medicinal Chemistry 2004, 47:6466-6475.
65. Brusselmans K., Vrolix R., Verhoeven G., Swinnen J.V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. Journal of Biological Chemistry 2005, 280:5636-5645.
66. Kim M.H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Journal of Cellular Biochemistry 2003, 89:529-538.
67. Reiners J.J., Clift R., Mathieu P. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis 1999, 20:1561-1566.
68. Way T.D., Kao M.C., Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. Journal of Biological Chemistry 2004, 279:4479-4489.
69. Kim J.S., Eom J.I., Cheong J.W., Choi A.J., Lee J.K., Yang W.I., Min Y.H. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clinical Cancer Research 2007, 13:1019-1028.
70. Alternative Herbal Index. http://www.altnature.com/gallery.
71. Graf J. Herbal anti-inflammatory agents for skin disease. Skin Therapy Letter 2000, 5:3-5.
72. Kim H.Y., Kim O.H., Sung M.K. Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers. Journal of the American College of Nutrition 2003, 22:217-223.
73. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual Review of Nutrition 2001, 21:381-406.
74. O'Prey J., Brown J., Fleming J., Harrison P.R. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochemical Pharmacology 2003, 66:2075-2088.
75. Thiery-Vuillemin A., Nguyen T., Pivot X., Spano J.P., Dufresnne A., Soria J.C. Molecularly targeted agents: Their promise as cancer chemopreventive interventions. European Journal of Cancer 2005, 41:2003-2015.
76. Nielsen S.E., Young J.F., Daneshvar B., Lauridsen S.T., Knuthsen P., Sandstrom B., Dragsted L.O. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. The British Journal of Nutrition 1999, 81:447-455.
77. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 2003, 3:768-780.
78. Arai Y., Watanabe S., Kimira M., Shimoi K., Mochizuki R., Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. Journal of Nutrition 2000, 130:2243-2250.
79. Janssen K., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., Katan M.B. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. American Journal of Clinical Nutrition 1998, 67:255-262.
80. Way T.D., Kao M.C., Lin J.K. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Letters 2005, 579:145-152.
81. Weldon C.B., McKee A., Collins-Burow B.M., Melnik L.I., Scandurro A.B., McLachlan J.A., Burow M.E., Beckman B.S. PKC-mediated survival signaling in breast carcinoma cells: A role for MEK1-AP1 signaling. International Journal of Oncology 2005, 26:763-768.
82. Yin F., Giuliano A.E., Law R.E., Van Herle A.J. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Research 2001, 21:413-420.
83. Choi E.J., Kim G.H. Apigenin causes G (2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. Journal of Nutritional Biochemistry 2008, 20:285-290.
84. Wang C., Kurzer M.S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutrition and Cancer 1997, 28:236-247.
85. Wang C., Kurzer M.S. Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutrition and Cancer 1998, 31:90-100.
86. Collins-Burow B.M., Burow M.E., Duong B.N., McLachlan J.A. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutrition and Cancer 2000, 38:229-244.
87. Long X., Fan M., Bigsby R.M., Nephew K.P. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Molecular Cancer Therapeutics 2008, 7:2096-2108.
88. Zhang S., Yang X., Morris M.E. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharmaceutical Research 2004, 21:1263-1273.
89. Stroheker T., Picard K., Lhuguenot J.C., Canivenc-Lavier M.C., Chagnon M.C. Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines. Food and Chemical Toxicology 2004, 42:887-897.
90. Seo H.S., DeNardo D.G., Jacquot Y., Laïos I., Vidal D.S., Zambrana C.R., Leclercq G., Brown P.H. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Research and Treatment 2006, 99:121-134.
91. Van Meeuwen J.A., Korthagen N., de Jong P.C., Piersma A.H., Van den Berg M. (Anti) estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicology and Applied Pharmacology 2007, 221:372-383.
92. Menendez J.A., Vazquez-Martin A., Oliveras-Ferraros C., Garcia-Villalba R., Carrasco-Pancorbo A., Fernandez-Gutierrez A., Segura-Carretero A. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. International Journal of Molecular Medicine 2008, 22:433-439.
93. Lee S.H., Ryu J.K., Lee K.Y., Woo S.M., Park J.K., Yoo J.W., Kim Y.T., Yoon Y.B. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Letters 2008, 259:39-49.
94. Zheng P.W., Chiang L.C., Lin C.C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sciences 2005, 76:1367-1379.
95. Czyz J., Madeja Z., Irmer U., Korohoda W., Hulser D.F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. International Journal of Cancer 2005, 114:12-18.
96. Wu C., Chen F., Rushing J.W., Wang X., Kim H.J., Huang G., Haley-Zitlin V., He G. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. Journal of Medical Food 2006, 9:55-61.
97. Wang W., Heideman L., Chung C.S., Pelling J.C., Koehler K.J., Birt D.F. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Molecular Carcinogenesis 2000, 28:102-110.
98. Wang W., VanAlstyne P.C., Irons K.A., Chen S., Stewart J.W., Birt D.F. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutrition and Cancer 2004, 48:106-114.
99. Takagaki N., Sowa Y., Oki T., Nakanishi R., Yogosawa S., Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. International Journal of Oncology 2005, 26:185-189.
100. Chung C.S., Jiang Y., Cheng D., Birt D.F. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin. Molecular Carcinogenesis 2007, 46:773-782.
101. Farah M., Parhar K., Moussavi M., Eivemark S., Salh B. 5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis. American Journal of Physiology Gastrointestinal and Liver Physiology 2003, 285:919-928.
102. Au A., Li B., Wang W., Roy H., Koehler K., Birt D. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Nutrition and Cancer 2006, 54:243-251.
103. Svehlikova V., Bennett R.N., Mellon F.A., Needs P.W., Piacente S., Kroon P.A., Bao Y. Isolation, identification and stability of acylated derivatives of apigenin 7-O-glucoside from chamomile (Chamomilla recutita [L.] Rauschert). Phytochemistry 2004, 65:2323-2332.
104. Al-Fayez M., Cai H., Tunstall R., Steward W.P., Gescher A.J. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemotherapy and Pharmacology 2006, 58:816-825.
105. Vargo M.A., Voss O.H., Poustka F., Cardounel A.J., Grotewold E., DoseffA.I. Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochemical Pharmacology 2006, 72:681-692.
106. Navarro-Núñez L., Lozano M.L., Palomo M., Martínez C., Vicente V., Castillo J., Benavente-García O., Diaz-Ricart M., Escolar G., Rivera J. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. Journal of Agricultural and Food Chemistry 2008, 56:2970-2976.
107. Chen D., Daniel K.G., Chen M.S., Kuhn D.J., Landis-Piwowar K.R., Dou Q.P. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochemical Pharmacology 2005, 69:1421-1432.
108. Abaza L., Talorete T.P., Yamada P., Kurita Y., Zarrouk M., Isoda H. Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract. Bioscience Biotechnology and Biochemistry 2007, 71:1306-1312.
109. Monasterio A., Urdaci M.C., Pinchuk I.V., Lopez-Moratalla N., Martinez-Irujo J. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Journal of Nutrition Cancer 2004, 50:90-100.
110. Horvathova K., Novotny L., Vachalkova A. The free radical scavenging activity of four flavonoids determined by the comet assay. Neoplasma 2003, 50:291-295.
111. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:4790-4795.
112. Li Z.D., Liu L.Z., Shi X., Fang J., Jiang B.H. Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation. Biochemical and Biophysical Research Communications 2007, 357:517-523.
113. Watanabe N., Hirayama R., Kubota N. The chemopreventive flavonoid apigenin confers radiosensitizing effect in human tumor cells grown as monolayers and spheroids. Journal of Radiation Research (Tokyo) 2007, 48:45-50.
114. Lee W.J., Chen W.K., Wang C.J., Lin W.L., Tseng T.H. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology 2008, 226:178-191.
115. Engelmann C., Blot E., Panis Y., Bauer S., Trochon V., Nagy H.J., Lu H., Soria C. Apigenin - strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo. Phytomedicine 2002, 9:489-495.
116. Fang J., Zhou Q., Liu L.Z., Xia C., Hu X., Shi X., Jiang B.H. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis 2007, 28:858-864.
117. Zhu F., Liu X.G., Liang N.C. Effect of emodin and apigenin on invasion of human ovarian carcinoma HO-8910PM cells in vitro. Ai Zheng 2003, 22:358-362.
118. Hu X.W., Meng D., Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 2008, 29:2369-2376.
119. Kanerva A., Raki M., Ranki T., Särkioja M., Koponen J., Desmond R.A., Helin A., Stenman U.H., Isoniemi H., Höckerstedt K., Ristimäki A., Hemminki A. Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. Journal of Gene Medicine 2007, 9:3-9.
120. Knowles L.M., Zigrossi D.A., Tauber R.A., Hightower C., Milner J.A. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutrition and Cancer 2000, 38:116-122.
121. Lee S.C., Kuan C.Y., Yang C.C., Yang S.D. Bioflavonoids commonly and potently induce tyrosine dephosphorylation/inactivation of oncogenic proline-directed protein kinase FA in human prostate carcinoma cells. Anticancer Research 1998, 18:1117-1121.
122. Morrissey C., O'Neill A., Spengler B., Christoffel V., Fitzpatrick J.M., Watson R.W. Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells. Prostate 2005, 63:131-142.
123. Shukla S., Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Clinical Cancer Research 2004, 10:3169-3178.
124. Shukla S., Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Molecular Cancer Therapeutics 2006, 5:843-852.
125. Shukla S., Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radical Biology and Medicine 2008, 44:1833-1845.
126. Shukla S., Gupta S. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study. Molecular Carcinogenesis 2009, 48:243-252.
127. Kaur P., Shukla S., Gupta S. Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: An in vitro and in vivo study. Carcinogenesis 2008, 29:2210-2217.
128. Mirzoeva S., Kim N.D., Chiu K., Franzen C.A., Bergan R.C., Pelling J.C. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Molecular Carcinogenesis 2008, 47:686-700.
129. McVean M., Xiao H., Isobe K., Pelling J.C. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 2000, 21:633-639.
130. Li B., Birt D.F. In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin. Pharmaceutical Research 1996, 13:1710-1715.
131. Li B., Pinch H., Birt D.F. Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin. Pharmaceutical Research 1996, 13:1530-1534.
132. Tong X., Van Dross R.T., Abu-Yousif A., Morrison A.R., Pelling J.C. Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition. Molecular and Cellular Biology 2007, 27:283-296.
133. Van Dross R.T., Hong X., Essengue S., Fischer S.M., Pelling J.C. Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expression by apigenin in mouse keratinocytes: role of USF transcription factors. Molecular Carcinogenesis 2007, 46:303-314.
134. Caltagirone S., Rossi C., Poggi A., Ranelletti F.O., Natali P.G., Brunetti M., Aiello F.B., Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer 2000, 87:595-600.
135. Schroder-van der Elst J.P., van der Heide D., Romijn J.A., Smit J.W. Differential effects of natural flavonoids on growth and iodide content in a human Na+/I- symporter-transfected follicular thyroid carcinoma cell line. European Journal of Endocrinology 2004, 150:557-564.
136. O'Toole S.A., Sheppard B.L., Sheils O., O'Leary J.J., Spengler B., Christoffel V. Analysis of DNA in endometrial cancer cells treated with phyto-estrogenic compounds using comparative genomic hybridisation microarrays. Planta Medica 2005, 71:435-439.
137. Wu K., Yuan L.H., Xia W. Inhibitory effects of apigenin on the growth of gastric carcinoma SGC-7901 cells. World Journal of Gastroenterology 2005, 11:4461-4464.
138. Eaton E.A., Walle U.K., Lewis A.J., Hudson T., Wilson A.A., Walle T. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase: Potential role in drug metabolism and chemoprevention. Drug Metabolism and Disposition 1996, 24:232-237.
139. Watjen W., Weber N., Lou Y.J., Wang Z.Q., Chovolou Y., Kampkotter A., Kahl R., Proksch P. Prenylation enhances cytotoxicity of apigenin and liquiritigenin in rat H4IIE hepatoma and C6 glioma cells. Food and Chemical Toxicology 2007, 45:119-124.
140. Yee S.B., Lee J.H., Chung H.Y., Im K.S., Bae S.J., Choi J.S., Kim N.D. Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells. Archives of Pharmacal Research 2003, 26:151-156.
141. Jeyabal P.V., Syed M.B., Venkataraman M., Sambandham J.K., Sakthisekaran D. Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats. Molecular Carcinogenesis 2005, 44:11-20.
142. Sanderson J.T., Hordijk J., Denison M.S., Springsteel M.F., Nantz M.H., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicological Sciences 2004, 82:70-79.
143. Ohno S., Shinoda S., Toyoshima S., Nakazawa H., Makino T., Nakajin S. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. Journal of Steroid Biochemistry and Molecular Biology 1999, 80:355-363.
144. Torkin R., Lavoie J.F., Kaplan D.R., Yeger H. Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma. Molecular Cancer Therapeutics 2005, 4:1-11.
145. Das A., Banik N.L., Ray S.K. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. International Journal of Cancer 2006, 119:2575-2585.
146. Becker B., Kuhn U., Hardewig-Budny B. Double-blind, randomized evaluation of clinical efficacy and tolerability of an apple pectin-chamomile extract in children with unspecific diarrhea. Arzneimittelforschung 2006, 56:387-393.
147. Savino F., Cresi F., Castagno E., Silvestro L., Oggero R.A. Randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytotherapy Research 2005, 19:335-340.
148. Kupfersztain C., Rotem C., Fagot R., Kaplan B. The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clinical and Experimental Obstetrics and Gynecology 2003, 30:203-206.
149. Nakamura H., Moriya K., Oda S., Yano E., Kakuta H. Changes in the parameters of autonomic nervous system and emotion spectrum calculated from encephalogram after drinking chamomile tea. Aroma Research 2002, 3:251-255.
150. Kyokong O., Charuluxananan S., Muangmingsuk V., Rodanant O., Suornsug. K., Punyasang W. Efficacy of chamomile-extract spray for prevention of post-operative sore throat. Journal of the Medical Association of Thailand 2002, 85:S180-S185.
151. Burns E., Blamey C., Ersser S.J., Lloyd A.J., Barnetson L. The use of aromatherapy in intrapartum midwifery practice - an observational study. Complementary Therapies in Nursing and Midwifery 2000, 6:33-34.
152. de la Motte S., Bose-O'Reilly S., Heinisch M., Harrison F. Double-blind comparison of an apple pectin-chamomile extract preparation with placebo in children with diarrhea. Arzneimittelforschung 1997, 47:1247-1249.
153. Fidler P., Lorinzi C.L., O'Fallon J.R., Leitch J.M., Lee J.K., Hayes D.L., Novotny P., Clemens-Schutjer D., Bartel J., Michalak J.C. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 1996, 77:522-525.
154. Korting H.C., Schafer-Korting M., Hart H., Laux P., Schmid M. Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose. European Journal of Clinical Pharmacology 1993, 44:315-318.
155. Weizman Z., Alkrinawi S., Goldfarb D., Bitran C. Efficacy of herbal tea preparation in infantile colic. Journal of Pediatrics 1993, 122:650-652.
156. Roberts A., Williams J.M.G. The effect of olfactory stimulation on fluency, vividness of imagery and associated mood - a preliminary study. The British Journal of Medical Psychology 1992, 6:197-199.
157. Glowania H.J., Raulin C., Swoboda M. Effect of chamomile on wound healing - a clinical double-blind study. Zeitschrift fur Hautkrankheiten 1987, 62:1267-1271.
158. Gould L., Goswami M.K., Reddy C.V., Gomprecht R.F. The cardiac effects of tea. Journal of Clinical Pharmacology 1973, 13:469-474.